We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.

Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Nasal potential difference

New guidelines on non CF disorders related to the CFTR gene

  • Read more about New guidelines on non CF disorders related to the CFTR gene

Clinical presentation and basic defect of the CFTR genotype p.Phe508del / p.Arg117His in a mother and her monozygous twin daughters

  • Read more about Clinical presentation and basic defect of the CFTR genotype p.Phe508del / p.Arg117His in a mother and her monozygous twin daughters

Insights into the variability of Nasal Potential Difference, a biomarker of CFTR activity

  • Read more about Insights into the variability of Nasal Potential Difference, a biomarker of CFTR activity

Nasal Potential Difference in suspected Cystic Fibrosis patients with 5T: A step towards better characterization of a CFTR variant with varying clinical consequences

  • Read more about Nasal Potential Difference in suspected Cystic Fibrosis patients with 5T: A step towards better characterization of a CFTR variant with varying clinical consequences

Eluforsen: a potential new treatment option for people with cystic fibrosis (CF) due to the F508del gene mutation?

  • Read more about Eluforsen: a potential new treatment option for people with cystic fibrosis (CF) due to the F508del gene mutation?

Primary sclerosing cholangitis is associated with abnormalities in CFTR.

  • Read more about Primary sclerosing cholangitis is associated with abnormalities in CFTR.

A Multiple Reader Scoring System for Nasal Potential Difference Parameters

  • Read more about A Multiple Reader Scoring System for Nasal Potential Difference Parameters

Changes of CFTR functional measurements and clinical improvements in Cystic Fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor

  • Read more about Changes of CFTR functional measurements and clinical improvements in Cystic Fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)